Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor Graham Russell, Emeritus Professor of Musculoskeletal Pharmacology at NDORMS, has received the prestigious Gideon A. Rodan Excellence in Mentorship Award from the American Society for Bone and Mineral Research (ASBMR).

We are proud to congratulate Professor Graham Russell, Emeritus Professor of Musculoskeletal Pharmacology at NDORMS, on receiving the prestigious Gideon A. Rodan Excellence in Mentorship Award from the American Society for Bone and Mineral Research (ASBMR), at their annual meeting in Houston, Texas this September.

This award is given in recognition of outstanding support provided by a senior scientist who has helped promote the independent careers of young investigators in bone and mineral metabolism; it is certain that Prof Russell has and continues to encourage the careers of a vast number of successful musculoskeletal researchers.

This is the first time this award has been presented to a researcher from outside the US and is an excellent testimony to Professor Russell's achievements at NDORMS and within the field as a whole.

Similar stories

Patient and public involvement in Rheumatology research – embracing the wave of change

On launching the new OPEN ARMS PPI group in Oxford, Dr. Laura Coates explored the patient and public involvement (PPI) models of three academic centres in the UK to show how it benefits researchers, clinicians, and patients alike.

Neutrophil molecular wiring revealed: transcriptional blueprint of short-lived cells

Researchers publish the first blueprint of transcriptional factors that control neutrophil-driven inflammation in Nature Immunology.

NDORMS joins research partnership to understand links between overlapping long-term conditions

The links between different long-term health conditions will be explored in new research funded with a £2.5million grant from the Medical Research Council.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Researchers show the role of cilia in cartilage health

New research shows that disrupting primary cilia in juvenile, adolescent and early adulthood in cartilage stops it maturing correctly, making it more prone to thinning and the potential for osteoarthritis (OA) in later life.

New research could improve quality of life for Psoriatic Arthritis patients

Professors Laura Coates and Dani Prieto-Alhambra will take major roles in a new European Commission project to develop innovative personalised treatment options for people affected by psoriatic arthritis.